300
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Pattern of Antimicrobial Prescription at a Tertiary Health Center in Egypt: A Point Survey and Implications

ORCID Icon, , , , &
Pages 6365-6378 | Received 08 Jul 2022, Accepted 13 Oct 2022, Published online: 31 Oct 2022

References

  • Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750. doi:10.1016/S1473-3099(14)70780-7
  • Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972–978. doi:10.1001/archinte.163.8.972
  • Mittal AK, Bhardwaj R, Mishra P, Rajput SK. Antimicrobials misuse/overuse: adverse effect, mechanism, challenges and strategies to combat resistance. Open Biotechnol J. 2020;14(1):107–112. doi:10.2174/1874070702014010107
  • Abdulah R. Antibiotic abuse in developing countries. Pharm Regul Aff. 2012;1(2):1000e–1006e. doi:10.4172/2167-7689.1000e106
  • Vazquez-Lago JM, Lopez-Vazquez P, López-Durán A, Taracido-Trunk M, Figueiras A. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain. Fam Pract. 2012;29(3):352–360. doi:10.1093/fampra/cmr084
  • Habibzadeh F. Use and misuse of antibiotics in the Middle East. Lancet. 2013;382(1). doi:10.1016/S0140-6736(13)61636-0
  • Zakaa El-din M, Samy F, Mohamed A, Hamdy F, Yasser S, Ehab M. Egyptian community pharmacists’ attitudes and practices towards antibiotic dispensing and antibiotic resistance; a cross-sectional survey in Greater Cairo. Curr Med Res Opin. 2019;35(6):939–946. doi:10.1080/03007995.2018.1544119
  • Aly MM, Elchaghaby MA. The prescription pattern and awareness about antibiotic prophylaxis and resistance among a group of Egyptian pediatric and general dentists: a cross sectional study. BMC Oral Health. 2021;21(1):1–8. doi:10.1186/s12903-021-01685-y
  • Boucher HW, Bakken JS, Murray BE. The United Nations and the urgent need for coordinated global action in the fight against antimicrobial resistance. Ann Intern Med. 2016;165(11):812–813. doi:10.7326/M16-2079
  • World Health Organization . Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020 https://www.who.int/publications/i/item/9789240005587 Accessed16 October 2022.
  • World Health Organiation. Egypt: National action plan for antimicrobial resistance; 2018. Available from: https://www.who.int/publications/m/item/egypt-national-action-plan-for-antimicrobial-resistance. Accessed October 21, 2022.
  • World Health Organization. Antimicrobial Resistance Global Report on Surveillance: 2014 Summary https://apps.who.int/iris/handle/10665/112642 Accessed 16 October 2022.
  • World Health Organization. Antibiotic resistance: key facts. World Health Organization; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed September 30, 2022.
  • Ansari F, Erntell M, Goossens H, Davey P; Group EIIHCS. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–1504. doi:10.1086/644617
  • Zarb P, Goossens H. European surveillance of antimicrobial consumption (ESAC). Drugs. 2011;71(6):745–755. doi:10.2165/11591180-000000000-00000
  • Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Heal. 2018;6(6):e619–e629. doi:10.1016/S2214-109X(18)30186-4
  • Sulis G, Adam P, Nafade V, et al. Antibiotic prescription practices in primary care in low-and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2020;17(6):e1003139. doi:10.1371/journal.pmed.1003139
  • Sartelli M, Hardcastle C, Catena F, et al. Antibiotic use in low and middle-income countries and the challenges of antimicrobial resistance in surgery. Antibiotics. 2020;9(8):497. doi:10.3390/antibiotics9080497
  • Kurdi A, Hasan AJ, Baker KI, et al. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: the need for urgent action. Expert Rev Anti Infect Ther. 2020;19:1–10.
  • Talaat M, Saied T, Kandeel A, et al. A point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics. 2014;3(3):450–460. doi:10.3390/antibiotics3030450
  • Cardoso T, Ribeiro O, Aragão I, Costa-Pereira A, Sarmento A. Differences in microbiological profile between community-acquired, healthcare-associated and hospital-acquired infections. Acta Med Port. 2013;26(4):377–384. doi:10.20344/amp.208
  • Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO essential medicines list for optimal use—be AWaRe. Lancet Infect Dis. 2018;18(1):18–20. doi:10.1016/S1473-3099(17)30724-7
  • Zarb P, Amadeo B, Muller A, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother. 2011;66(2):443–449. doi:10.1093/jac/dkq430
  • Robert J, Péan Y, Varon E, et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother. 2012;67(4):1020–1026. doi:10.1093/jac/dkr571
  • Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect. 2013;14(1):73–156.
  • Alemkere G, Tenna A, Engidawork E. Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: identifying targets for antibiotic and health care resource stewardship. PLoS One. 2019;14(2):e0212661. doi:10.1371/journal.pone.0212661
  • Shrayteh ZM, Rahal MK, Malaeb DN. Practice of switch from intravenous to oral antibiotics. Springerplus. 2014;3(1):1–8. doi:10.1186/2193-1801-3-717
  • Pollack LA, Plachouras D, Sinkowitz-Cochran R, Gruhler H, Monnet DL, Weber JT. A concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panel. Infect Control Hosp Epidemiol. 2016;37(10):1201. doi:10.1017/ice.2016.115
  • Baddour LM, Yu VL, Klugman KP, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004;170(4):440–444. doi:10.1164/rccm.200311-1578OC
  • Kumar A, Zarychanski R, Light B, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38(9):1773–1785. doi:10.1097/CCM.0b013e3181eb3ccd
  • Davey P, Ferech M, Ansari F, Muller A, Goossens H. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother. 2008;62(6):1441–1447. doi:10.1093/jac/dkn386
  • Calabresi L, Pazzucconi F, Ferrara S. Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in healthy volunteers. Pharmacol Res. 2004;49(5):493–499. doi:10.1016/j.phrs.2003.10.010
  • Tanaka H, Matsumoto K, Ueno K, et al. Effect of clarithromycin on steady-state digoxin concentrations. Ann Pharmacother. 2003;37(2):178–181. doi:10.1177/106002800303700202
  • Davydov L, Yermolnik M, Cuni LJ. Warfarin and amoxicillin/clavulanate drug interaction. Ann Pharmacother. 2003;37(3):367–370. doi:10.1345/aph.1C243
  • Gillum JG, Israel DS, Scott RB, Climo MW, Polk RE. Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers. Antimicrob Agents Chemother. 1996;40(7):1715–1716. doi:10.1128/AAC.40.7.1715
  • Batty KT, Davis TM, Ilett KF, Dusci LJ, Langton SR. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 1995;39(3):305–311. doi:10.1111/j.1365-2125.1995.tb04453.x
  • Loi CM, Parker BM, Cusack BJ, Vestal RE. Aging and drug interactions. III. Individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers. J Pharmacol Exp Ther. 1997;280(2):627–637.
  • Randinitis EJ, Alvey CW, Koup JR, et al. Drug interactions with clinafloxacin. Antimicrob Agents Chemother. 2001;45(9):2543–2552. doi:10.1128/AAC.45.9.2543-2552.2001
  • Efthymiopoulos C, Bramer SL, Maroli A, Blum B. Theophylline and warfarin interaction studies with grepafloxacin. Clin Pharmacokinet. 1997;33(1):39–46. doi:10.2165/00003088-199700331-00008
  • Fish DN. Fluoroquinolone adverse effects and drug interactions. Pharmacother J Hum Pharmacol Drug Ther. 2001;21(10P2):253S–272S. doi:10.1592/phco.21.16.253S.33993
  • Willemsen I, Groenhuijzen A, Bogaers D, Stuurman A, van Keulen P, Kluytmans J. Appropriateness of antimicrobial therapy measured by repeated prevalence surveys. Antimicrob Agents Chemother. 2007;51(3):864–867. doi:10.1128/AAC.00994-06